Sabaa International Company for Pharmaceutical and Chemical Industry (EGX:SIPC)

Market Cap	1.41B +102.9%
Revenue (ttm)	40.72M -6.3%
Net Income	-3.98M
EPS	-0.02
Shares Out	250.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,559,446
Open	5.50
Previous Close	5.50
Day's Range	5.55 - 5.89
52-Week Range	2.62 - 7.28
Beta	0.48
Analysts	n/a
Price Target	n/a
Est. Earnings	Mar 2, 2027

About EGX:SIPC

Sabaa International Company for Pharmaceutical and Chemical Industry operates as a healthcare company in Egypt. It provides hard gelatin capsules, such as acitretin; film coated tablets, including saboctic, topiramate, and tolterodine; and tablets comprising claudol and flamogen E.C.T. The company also offers generics, OTCs, food supplements, and veterinary products, as well as medicine trials laboratory services. Sabaa International Company for Pharmaceutical and Chemical Industry was incorporated in 2000 and is based in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 2000
• Employees: 165
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: SIPC

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 14, 2026

Data Sources Report a data error